Barriers to clinical research participation in a diabetes randomized clinical trial

Social Science and Medicine

Volumn 68, Issue 6, 2009, Pages 1069-1074

  Robiner, William N ^a   Yozwiak, John A ^a   Bearman, Diane L ^a   Strand, Trudy D ^a   Strasburg, Katherine R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adherence; Barriers; Clinical trial; Research participation

Indexed keywords

CHILD CARE; DIABETES; DRUG USER; PARTICIPATORY APPROACH; RESEARCH WORK; STRATEGIC APPROACH;

ADULT; AGE FACTORS; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; HUMAN EXPERIMENTATION; HUMANS; MALE; MEDICATION ADHERENCE; RESEARCH DESIGN; SEX FACTORS; SOCIAL SUPPORT;

EID: 61649099807     PISSN: 02779536     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.socscimed.2008.12.025     Document Type: Article

References (31)

1. Andersen R. A behavioral model of families' use of health services. (Research Series No. 25) (1968), Center for Health Administration Studies, University of Chicago, Chicago
2. Bourgeois J.A. Compliance with psychiatric treatment in primary care: review and strategies. Primary Psychiatry 12 6 (2005) 40-47
3. Collins J.F., Williford W.O., Weiss D.G., Bingham S.F., and Klett C.J. Planning patient recruitment: fantasy and reality. Statistics in Medicine 3 4 (1984) 435-443
4. Cramer J.A. Identifying and improving compliance patterns: a composite plan for health care providers. In: Cramer J.A., and Spilker B. (Eds). Patient compliance in medical practice and clinical trials (1991), Raven Press, New York 387-403
5. Cramer J.A. Overview of methods to enhance patient compliance. In: Cramer J.A., and Spilker B. (Eds). Patient compliance in medical practice and clinical trials (1991), Raven Press, New York 3-10
6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329 (1993) 977-986
7. Eggleston K.S., Coker A.L., Das I.P., Cordray S.T., and Luchok K.J. Understanding barriers for adherence to follow-up care for abnormal pap tests. Journal of Women's Health 16 (2007) 311-330
8. Gamache V. Minimizing volunteer dropout. CenterWatch 19 12 (2002) 9-12
9. Glasgow R.E. Compliance to diabetes regimens: conceptualization, complexity, and determinants. In: Cramer J.A., and Spilker B. (Eds). Patient compliance in medical practice and clinical trials (1991), Raven Press, New York 209-224
10. Janz N.K., and Becker M.H. The Health Belief Model: a decade later. Health Education Quarterly 11 (1984) 1-47
11. Kramer J., Jacobson A., Ryan C., Murphy W., and the DCCT Research Group. Psychological aspects of the DCCT. In: Bradley C., Home P., and Christie M. (Eds). The technology of diabetes care: Converging medical and psychosocial perspectives (1994), Churchill Harwood, New York 122-139
12. Krueger K.P., Berger B.A., and Felkey B. Medication adherence and persistence: a comprehensive review. Advances in Therapy 22 (2005) 313-356
13. Lasagna L., and Hutt P.B. Health care, research, and regulatory impact of noncompliance. In: InCramer J.A., and Spilker B. (Eds). Patient compliance in medical practice and clinical trials (1991), Raven Press, New York 393-403
14. Lowton K. Trials and tribulations: understanding motivations for clinical research participation amongst adults with cystic fibrosis. Social Science & Medicine 61 (2005) 1854-1865
15. Mauer M., Drummond K., and for the International Diabetic Nephropathy Study Group (IDNSG). The early natural history of nephropathy in type 1 diabetes. I. Study design and baseline characteristics of the study participants. Diabetes 51 (2002) 1572-1579
16. Mauer M., Zinman B., Gardiner R., Drummond K.N., Suissa S., Donnelly S.M., et al. ACE-I and ARBs in early diabetic nephropathy. Journal of the Renin-Angiotensin-Aldosterone System 3 (2002) 262-269
17. Mauer, M., Zinman, B., Gardiner, R., Suissa, S., Sinaiko, A. R., & Strand, T. D., et al. Effects of enalapril and losartan on nephropathy and retinopathy in Type 1 diabetic patients, submitted for publication.
18. McCullock-Melnyk K.A. Barriers: a critical review of recent literature. Nursing Research 37 4 (1988) 196-201
19. Moher D., Schulz K.F., Altman D., and for the Consort Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Journal of the American Medical Association 285 (2001) 1987-1991
20. Pharmaceutical Interventions Working Group. Discussion at the conference on "Adherence to behavioral and pharmacological interventions in clinical research on older adults (1998), Wake Forest University School of Medicine, Winston-Salem, NC
21. Probstfield J.L., Russell M.L., Insull Jr. W., and Yusuf S. Dropouts from a clinical trial, their recovery, and characterization: a basis for dropout management and prevention. In: Shumaker S.A., Schron E.B., and Ockene J.K. (Eds). The handbook of health behavior change (1990), Springer, New York 376-400
22. Reif S., Golin C.E., and Smith S.R. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences. AIDS Care 17 (2005) 558-565
23. Robiner W.N. Enhancing adherence in clinical research. Contemporary Clinical Trials 26 (2005) 59-77
24. Robiner W.N., and Keel P.K. Self-care behaviors and adherence in diabetes mellitus. Seminars in Clinical Neuropsychiatry 2 (1997) 40-56
25. Rosen M.I., Rigsby M.O., Salahi J.T., Ryan C.E., and Cramer J.A. Electronic monitoring and counseling to improve medication adherence. Behaviour Research and Therapy 42 (2004) 409-422
26. Rosenstock I.M. Why people use health services. Milbank Memorial Fund Quarterly 44 (1966) 94-127
27. Ross S., Grant A., Counsell C., Gillespie W., Russell I., and Prescott R. Barriers to participation in randomized controlled trials: a systematic review. Journal of Clinical Epidemiology 52 (1999) 1143-1156
28. Rozanski A. Integrating psychologic approaches into the behavioral management of cardiac patients. Psychosomatic Medicine 67 (2005) S67-S73
29. Spilker B. Methods of assessing and improving patient compliance in clinical trials. In: Cramer J.A., and Spilker B. (Eds). Patient compliance in medical practice and clinical trials (1991), Raven Press, New York 37-56
30. Ward-Begnoche W., and Speaker S. Overweight youth: changing behaviors that are barriers to health. Journal of Family Practice 55 (2006) 957-963
31. Zinman B. Translating the diabetes control and complications trial (DCCT) into clinical practice: overcoming the barriers. Diabetologia 40 Suppl. 2 (July 1997) S88-S90